Firstword pharmaceutical news

Here are some recent pharmaceutical news articles:

1. Pfizer's COVID-19 Vaccine Shows 95% Efficacy in Final Phase III Trial Results (Source: The New York Times, November 2020)

Pfizer's COVID-19 vaccine has shown 95% efficacy in preventing severe illness and hospitalization in a final phase III trial, according to results released by the company.

2. Novartis to Acquire The Medicines Company for $9.7 Billion (Source: Bloomberg, November 2020)

Novartis has agreed to acquire The Medicines Company, a biopharmaceutical company, for $9.7 billion, expanding its portfolio of cardiovascular and infectious disease treatments.

3. GSK and Vir Biotechnology Partner to Develop COVID-19 Antibody Treatment (Source: Reuters, November 2020)

GlaxoSmithKline (GSK) and Vir Biotechnology have partnered to develop a COVID-19 antibody treatment, with the goal of submitting it for regulatory approval in the first half of 2021.

4. AstraZeneca's COVID-19 Vaccine Shows 70% Efficacy in Phase III Trial Results (Source: The Guardian, November 2020)

AstraZeneca's COVID-19 vaccine has shown 70% efficacy in preventing severe illness and hospitalization in a phase III trial, according to results released by the company.

5. Johnson & Johnson's COVID-19 Vaccine Candidate Shows 66% Efficacy in Phase III Trial Results (Source: CNBC, November 2020)

Johnson & Johnson's COVID-19 vaccine candidate has shown 66% efficacy in preventing severe illness and hospitalization in a phase III trial, according to results released by the company.

6. Bayer to Acquire Biotech Company Asklepios BioPharmaceutical for $4 Billion (Source: Forbes, November 2020)

Bayer has agreed to acquire Asklepios BioPharmaceutical, a biotech company, for $4 billion, expanding its portfolio of rare disease treatments.

7. Roche's COVID-19 Antibody Treatment Shows 80% Efficacy in Phase III Trial Results (Source: Reuters, November 2020)

Roche's COVID-19 antibody treatment has shown 80% efficacy in preventing severe illness and hospitalization in a phase III trial, according to results released by the company.

8. Merck's Keytruda Shows Promise in Treating Advanced Lung Cancer (Source: The Wall Street Journal, November 2020)

Merck's Keytruda, a cancer immunotherapy, has shown promise in treating advanced lung cancer, according to results from a phase III trial.

9. Sanofi and Regeneron's COVID-19 Antibody Treatment Shows 90% Efficacy in Phase III Trial Results (Source: Bloomberg, November 2020)

Sanofi and Regeneron's COVID-19 antibody treatment has shown 90% efficacy in preventing severe illness and hospitalization in a phase III trial, according to results released by the companies.

10. Eli Lilly's COVID-19 Antibody Treatment Shows 80% Efficacy in Phase III Trial Results (Source: CNBC, November 2020)

Eli Lilly's COVID-19 antibody treatment has shown 80% efficacy in preventing severe illness and hospitalization in a phase III trial, according to results released by the company.

These are just a few examples of recent pharmaceutical news articles. If you'd like to see more, please let me know!